Making HIV-related data widely available, easily accessible & locally relevant to inform public health decision making.
AIDSVu is an interactive online mapping tool that visualizes the impact of the HIV epidemic on communities across the United States to increase disease awareness and promote data-driven public health decision-making. AIDSVu is presented by Emory University’s Rollins School of Public Health in partnership with Gilead Sciences, Inc. and the Center for AIDS Research at Emory University (CFAR). The site utilizes data from the Centers for Disease Control and Prevention (CDC), local health departments, and other high-quality sources to allow users to explore the HIV epidemic at the state-, county-, and ZIP Code-levels. The map visualizes HIV-related data by race/ethnicity, sex, age, and transmission category, and shows how HIV is related to various social determinants of health, such as high school education and poverty.
AIDSVu allows users to locate services for HIV prevention, testing, and care, and also includes NIH-funded HIV prevention, vaccine, and treatment trial locations. The site also has data pages with profiles for 36 U.S. cities, 48 counties with the highest burden of new HIV diagnoses that are prioritized for Phase 1 of Ending the HIV Epidemic: A Plan for America initiative, 50 states, DC, Puerto Rico, 4 regions, and the nation, offering easy-to-understand, printable snapshots that summarize the impact of HIV and other sexually transmitted diseases.
Now in its 9th year, AIDSVu continues to expand the data, maps, and tools available on its main website, as well as on Powered by AIDSVu projects that visualize public health data. In 2015, the inaugural Powered By AIDSVu project, HIVContinuum.org, was released to map outcomes across five stages of the HIV care continuum. In 2017, the second Powered By AIDSVu project, HepVu.org, was established to visualize the first standardized state-level estimates of Hepatitis C prevalence across the U.S.
The project is led by Patrick Sullivan, PhD, Professor of Epidemiology and Co-Director of the CFAR Prevention Science Core. Dr. Sullivan worked in HIV/AIDS surveillance for 12 years at U.S. Centers for Disease Control and Prevention (CDC), including five years as a Branch Chief overseeing HIV/AIDS surveillance activities. Dr. James Curran, Dean of the Rollins School of Public Health at Emory University and Co-Director of the Emory CFAR, is the Chair of the Advisory Committee for the project. AIDSVu receives ongoing support and guidance from the following groups:
- The AIDSVu Advisory Committee, which consists of key stakeholders who provide oversight and guidance for the project;
- The AIDSVu Technical Advisory Group, which consists of HIV surveillance technical experts who provide input regarding data and technical issues; and,
- The AIDSVu Prevention and Treatment Advisory Committee, which consists of HIV prevention professionals working in health departments across the country who provide input on maximizing AIDSVu’s value for prevention efforts.
The development of AIDSVu was guided by the following HIV/AIDS experts:
- Principle Scientist: Patrick Sullivan, DVM, PhD, Professor, Department of Epidemiology
Rollins School of Public Health
- Scientist: Amanda D. Castel, MD, MPH, AAHIVS, Associate Professor and Co-Director MSPHMEID Program, Department of Epidemiology and Biostatistics, Milken Institute School of Public Health, George Washington University
AIDSVu Advisory Committee
- Gregg Alton, Chief Patient Officer, Gilead Sciences, Inc.
- James Curran, MD, Dean, Rollins School of Public Health, Emory University
- Nanette Benbow, Senior Policy Advisor and Research Assistant Professor, Northwestern University, Feinberg School of Medicine
- Guillermo Chacon, President, Latino Commission on AIDS
- Carlos del Rio, MD, Hubert Professor and Chair of the Department of Global Health at the Rollins School of Public Health and Professor of Medicine in the Division of Infectious Diseases at Emory University School of Medicine, co-Director of the Emory Center for AIDS Research (CFAR)
- Carl Dieffenbach, PhD, Director, Division of AIDS (DAIDS), National Institute of Allergy and Infectious Diseases, National Institutes of Health
- Evelyn Foust, MPH, CPM, Branch Head, Communicable Diseases, North Carolina Division of Public Health
- Kevin Frost, Chief Executive Officer, amfAR
- Marjorie A. Innocent, PhD, Senior Director of Health Programs, NAACP
- Jennifer Kates, PhD, Vice President and Director of Global Health & HIV Policy, Kaiser Family Foundation
- Marsha Martin, DSW, Prior Director, Urban Coalition for HIV/AIDS Prevention Services
- Henry Masur, MD, Chief, Critical Care Medicine Department, NIH Clinical Center
- Eugene McCray, MD, Director, Division of HIV/AIDS prevention (DHAP), National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention
- Jonathan Mermin, MD, MPH, RADM, Director, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention
- Gregorio Millett, MPH, Vice President and Director, Public Policy, amFAR
- Michael Mugavero, MD, MHSc, Associate Professor, Division of Infectious Diseases, University of Alabama at Birmingham, School of Medicine
- Ron Valdiserri, MD, MPH, Senior Research Associate, Johns Hopkins University, Bloomberg School of Public Health, Former Deputy Assistant Secretary for Health, Infectious Diseases, U.S. Department of Health and Human Services
AIDSVu Technical Advisory Group
- Kathleen Brady, MD, PhD, Director of HIV Epidemiology for the Philadelphia Department of Public Health
- Natalie Cramer, Senior Director, Prevention, Health Care Access, and Policy, National Alliance of State & Territorial AIDS Directors
- Miranda Fanning, Branch Chief, Division of Policy and Data, HIV/AIDS Bureau, Health Resources and Services Administration
- Virginia Hu, Supervising Epidemiologist, HIV Surveillance, Division of HIV/STD Programs, Los Angeles County Department of Public Health
- Jeff Lauritsen, HIV/AIDS Epidemiologist, City of Chicago Department of Public Health
- Eve Mokotoff, Managing Director, HIV Counts, LLC
- Anna Satcher-Johnson, Centers for Disease Control and Prevention, Division of HIV/AIDS Prevention, HIV Incidence and Case Surveillance Branch
- Debbie Wendell, PhD, MPH, Data Management & Analysis Program Manager, STD/HIV Program, Louisiana Department of Health and Hospitals, Office of Public Health
- Lorene Maddox, Analysis Manager, HIV/AIDS Section, Bureau of Communicable Diseases Florida Department of Health
AIDSVu Prevention and Treatment Advisory Committee
- Jacob Dougherty, HIV Prevention Coordinator, Wisconsin Department of Health Services, HIV Program
- Pascale Wortley, MD, MPH, HIV Epidemiology Section Chief at the Georgia Department of Public Health
- Margaret Vaaler, PhD, Epidemiology and Supplemental Projects Group Manager, TB/HIV/STD Epidemiology and Surveillance Branch Texas Department of State Services